Chief Investment Officer, Canada Life Limited & Managing Director, Canada Life Asset Management Limited.
The Fund aims to achieve capital growth over any five-year period, after all costs and charges have been taken. The Fund’s comparator benchmark is the IA Mixed Investment 40%-85% Shares Sector.
LF Canlife Managed 40%-85% Fund
How the Fund is managed
For further details on the objective and investment policy, visit the Literature section to view fund KIIDs and Prospectus.
Capitalising on best investment opportunities
The Fund may not be appropriate for investors who plan to withdraw their money within five years of investing. It may be appropriate for investors seeking longer-term capital growth while also being able to accept a higher level of risk, in accordance with their risk profile.
The Fund offers a straightforward, well-diversified portfolio consisting of a broad range of global assets, including global equities, government and corporate bonds, with typically higher exposure to growth assets.
In-house management expertise
By investing in our own cost-effective range of actively managed funds, we are able to draw on the expertise of our in-house fund management teams and their long-term track records in fixed income, equities and property. The managers also have the ability to choose other external investment managers if an internal fund is not available or suitable.
This fund is available as part of the Core Range within Canada Life’s Retirement Account solution. For more information on this visit here.
The value of investments may fall as well as rise and investors may not get back the amount invested
The fund may invest in property funds that may be illiquid and subject to wide price spreads, both of which can impact the value of the fund. The value of the property is based on the opinion of a valuer and is therefore subjective.
To compare a Canada Life Asset Management fund with any other in our range, please click 'add holding' and type the name of the desired funds.
Glitzy tech stocks have hogged the limelight during 2020’s astonishing market rebound. Now it could be time for dowdier areas of the equity market to shine as vaccines make a return to normal in 2021 increasingly likely.